Pharmacokinetics and application of erythropoietin therapy: overview of epoetin alfa studies in Japan.
Shimosaka
A
A
Department of International Affairs, Pharmaceutical Division, Kirin Brewery Company, Ltd., Tokyo, Japan.
D006348:Cardiac Surgical Procedures; D003404:Creatinine / Q000097:blood; D004921:Erythropoietin / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007564:Japan; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008657:Metabolic Clearance Rate; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D011994:Recombinant Proteins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin; D003404:Creatinine